The Dermatitis Study

We are conducting a clinical trial to evaluate a potential new treatment for Atopic Dermatitis (AD), commonly known as eczema. AD is a chronic skin condition that causes persistent itching, redness, and flare-ups, impacting up to 20% of children and 3% of adults worldwide. Beyond the discomfort, it can also increase the risk of developing asthma and allergies.

Current treatments, such as creams and medications, often fall short or come with serious side effects when used long-term. That’s why there’s a need for safer, more effective solutions.

By participating in this study, you can contribute to the discovery of better treatments that aim to bring lasting relief and improve the quality of life for those living with eczema. Together, we can help create a future where managing eczema is simpler and more effective.

Call us on 1300 697 293 to discuss your eligibility today!